Directs the commissioner of health to publish guidance for incorporating placenta accreta spectrum screenings into routine prenatal care.
Impact
The introduction of this bill underscores the increasing emphasis on targeted health screenings within prenatal care frameworks. By formalizing the guidelines for PAS screenings, the bill intends to enhance healthcare providers' understanding of the condition, enabling them to identify at-risk pregnancies more efficiently. This could potentially lead to reduced complications for mothers and infants, elevating the standards of prenatal care across the state.
Summary
Bill A10514 seeks to amend the public health law in New York by mandating the commissioner of health to publish guidance on incorporating placenta accreta spectrum (PAS) screenings into routine prenatal care. This bill recognizes the significance of PAS, a serious pregnancy complication arising from abnormal placental attachment, and aims to inform healthcare practitioners on effective screening practices to ensure early detection and management of the condition.
Contention
While A10514 has garnered support from various health advocates prioritizing maternal and infant health, some may express concerns regarding resource allocation and practical implementation of the new guidelines in healthcare settings. Critics might argue that the additional screenings could impose burdens on healthcare facilities, requiring adjustments in training and resource management to align with the guidelines. Additionally, there may be discussions around the accessibility of care, especially for low-income populations who could be disproportionately affected by such changes.
Enacts the "children and recovering mothers (CHARM) act" to provide guidance, education and assistance to healthcare providers caring for expectant mothers with substance use disorder; provides for the screening of newborns for substance abuse exposure.
Requires the commissioner of health to consult with the office of addiction services and supports and relevant stakeholders as determined by such commissioner in addition to the office of mental health to publish guidance for incorporating maternal depression screenings into routine prenatal care; changes the effective date to eighteen months.
Requires the commissioner of health to consult with the office of addiction services and supports and relevant stakeholders as determined by such commissioner in addition to the office of mental health to publish guidance for incorporating maternal depression screenings into routine prenatal care; changes the effective date to eighteen months.
Directs the commissioner of health to make publicly available on the department of health website a report concerning access to applied behavior analysis for enrolled children diagnosed with autism spectrum disorder.
Establishes a duty to inform certain patients about the risks associated with cesarean section for patients undergoing a planned or unplanned primary cesarean section.
Establishes a duty to inform certain patients about the risks associated with cesarean section for patients undergoing a planned or unplanned primary cesarean section.